In the first government-backed survey conducted since Gardasil, the vaccination against the human papillomavirus (HPV), made its market debut in 2006, the Centers for Disease Control and Prevention (CDC) says about 25% of all American girls between the ages of…

In 2006, the US Food and Drug Administration (FDA) approved the vaccine, Gardasil, for girls and women between the ages of 9 and 26 as a means of preventing cervical cancer caused by the human papillomavirus (HPV).  In a September…

During 2007, more than 11,000 women in the United States were diagnosed with cervical cancer. Another 3,600 women died from it. The recently introduced Gardasil vaccine is expected to reduce the incidence of cervical cancer but it is most effective…

In a society where we are all “stressed out,” we can add another entry to our worry list.

Stress may increase the risk of developing cervical cancer. A study published this month in “Annals of Behavioral Medicine,” found that women who…

Obese white women are less likely to be screened for breast and cervical cancer than women who maintain a healthy weight according to a review of cancer screening studies conducted by researchers at the University of North Carolina at Chapel…

Merck & Co., Inc., has announced that the US Food and Drug Administration (FDA) has accepted and designated as priority a review of GARDASIL, a vaccine against types 6, 11, 16, and 18 of the human papillomavirus (HPV), which is…

The Centers for Disease Control and Prevention (CDC) has just issued the alarming findings of its first ever survey of teen health which included sexually transmitted diseases (STDs). In the study, the National Health and Nutrition Examination Survey, 838 randomly…

A new study shows that the HPV vaccine, GARDASIL, reduced abnormal Pap test results by 43 percent compared to women not given the vaccine. GARDASIL is FDA approved against the human papilloma virus (HPV) strains (6, 11, 16, 18) believed…

A study released this week by the American Cancer Society outlined disturbing differences in survival rates among insured versus uninsured patients. The study, which appears in the March issue of The Lancet Oncology, is the first to use national data…

Stress could be a factor in whether or not women infected with malignancy-linked types of human papillomavirus (HPV) develop cervical cancer according to recent research.

According to new research, Human Papillomavirus (HPV) may be responsible for the development of oral cancer in men to a greater extent than previously thought. Statistics show that in the past four decades, incidence of oral cancer caused by HPV…

MedHeadlines - Two young women have died shortly after receiving Gardasil, a vaccine against human papillomavirus - one of the main causes of cervical cancer. The European Medicines Agency (EMEA) has reported that the two deaths occurred in Austria and…

Study done by the Cancer Research Epidemiology Unit at Oxford, indicates that oral contraceptive pills decrease woman’s risk of developing ovarian cancer. This positive effect may last for as long as 30 years after she has stopped taking the pill.…